Seung Ah Cho
1PUBLICATIONS
4CO-AUTHORS

Get your video featured.

Get your video featured.
Publications (1)
Sort by Publication Date:
|Mar 05, 2023
Efficacy and safety of enavogliflozin, a novel SGLT2 inhibitor, in Korean people with type 2 diabetes: A 24-week, multicentre, randomized, double-blind, placebo-controlled, phase III trial.Soo Heon Kwak, Kyung Ah Han, Kyung-Soo Kim
Pageof 1
